Oncolytics Biotech (ONCY) Jumps: Stock Rises 5%
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
ALXN
The Next Stock To See A 1,000% Gain?
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
3 Stocks Making Health-Care Investors Big Money Today
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
Alexion Pharma Hikes Outlook On French Reimbursement Deal
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
2:43 am Alexion Pharma: NICE confirms AGNSS Positive assessment that Eculizumab is a very effective treatment for aHUS patients and produces substantial quality-adjusted life year gains of a magnitude rarely seen for a new drug
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
British watchdog wants U.S. biotech Alexion to justify cost of drug
[Reuters – UK Focus] – Britain’s healthcare costs watchdog has asked U.S. biotech group Alexion Pharmaceuticals (NasdaqGS: ALXN – news) to explain the high price for its Soliris drug before deciding whether the treatment should be paid for by the state h moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who […]
NICE Confirms AGNSS Positive Assessment that Eculizumab (Soliris®) is a Very Effective Treatment for aHUS Patients and Produces Substantial Quality-Adjusted Life Year Gains of a Magnitude Rarely Seen for a New Drug
[Business Wire] – Alexion Pharmaceuticals is pleased that the National Institute for Health and Clinical Excellence Evaluation Committee has acknowledged that eculizumab (Soliri moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
Alexion’s $569,000 Drug Draws Data Demand From U.K. NICE
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
The Biggest S&P Winners So Far in 2014
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
